Finally, this study verified MAP7/7D2 expression was higher in NSCLC samples than in paratumor tissues of 20 NSCLC patients, but MAP2/4/6/7D3 expression was the opposite by RT-qPCR. The gene discussed is MAP2; the disease is non-small cell lung carcinoma.